Cynata Therapeutics Limited (ASX:CYP)

Cynata Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	77	34	53	22	52	72
Market Cap Growth	56.12%	-36.04%	136.00%	-56.47%	-28.71%	1.27%
Enterprise Value	72	23	42	6	25	47
Last Close Price	0.32	0.15	0.29	0.13	0.36	0.51
PS Ratio	41.04	17.98	22.88	13.57	6.64	46.80
PB Ratio	12.93	5.67	7.34	1.34	2.15	2.55
P/TBV Ratio	12.93	5.67	7.34	1.34	2.15	2.55
EV/Sales Ratio	38.36	12.41	18.06	3.65	3.19	30.68
Asset Turnover	0.24	0.24	0.17	0.07	0.28	0.07
Quick Ratio	4.24	4.24	5.39	7.30	9.23	16.71
Current Ratio	4.40	4.40	5.58	7.46	9.33	17.03
Return on Equity (ROE)	-142.29%	-142.29%	-81.37%	-70.17%	-20.81%	-34.05%
Return on Assets (ROA)	-77.08%	-77.08%	-46.70%	-40.86%	-13.42%	-19.85%
Return on Capital Employed (ROCE)	-160.70%	-160.70%	-141.70%	-89.00%	-25.30%	-26.60%
Earnings Yield	-12.14%	-27.71%	-18.39%	-63.59%	-10.56%	-10.63%
Buyback Yield / Dilution	-14.10%	-14.09%	-23.80%	-1.27%	-9.85%	-24.80%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.